Skip to main content

Want a detailed portfolio tracker?

Dianthus Therapeutics (DNTH) P/E (2023 - 2026)

Dianthus Therapeutics (DNTH) P/E from Sep 12, 2023 to Jul 20, 2026. The TTM Dianthus Therapeutics (DNTH) P/E is -24.76. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Dianthus Therapeutics (DNTH)

YearP/EChange
2026-24.76+155.33%
2025-9.70+26.30%
2024-7.68+525.65%
2023-1.23N/A

Comparison Dianthus Therapeutics (DNTH) P/E with competitors

Dianthus Therapeutics (DNTH) P/E is -24.76.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.30%
FGENFibroGen Inc0.24-100.97%
CHRSCoherus Biosciences Inc0.85-103.43%
FBIOFortress Biotech Inc0.95-103.83%
ORMPOramed Pharmaceuticals Inc1.50-106.07%
AGENAgenus Inc3.01-112.16%
INVAInnoviva Inc3.15-112.74%
VXRTVaxart Inc3.55-114.34%
CRMDCorMedix Inc3.63-114.66%
CVACCureVac N.V.4.45-117.96%
GLPGGalapagos NV4.86-119.62%
SRPTSarepta Therapeutics Inc4.88-119.72%
ABEOAbeona Therapeutics Inc5.39-121.76%
ABUSArbutus Biopharma Corp5.60-122.60%
ZVRAZevra Therapeutics Inc5.89-123.78%
SPROSpero Therapeutics Inc6.23-125.16%
CGENCompugen Ltd6.31-125.50%
RIGLRigel Pharmaceuticals6.87-127.76%
SLXNSilexion Therapeutics Corp7.30-129.47%
OMEROmeros Corporation9.26-137.40%
AUPHAurinia Pharmaceuticals Inc9.58-138.71%
PLXProtalix BioTherapeutics Inc10.89-143.99%
ACADAcadia Pharmaceuticals Inc11.73-147.37%
TBPHTheravance Biopharma Inc12.26-149.53%
ADMAAdma Biologics Inc12.42-150.16%
HRMYHarmony Biosciences Holdings Inc13.82-155.82%
SABSSAB Biotherapeutics Inc14.14-157.10%
NAGENiagen Bioscience Inc14.82-159.85%
INCYIncyte Corp15.82-163.91%
REGNRegeneron Pharmaceuticals Inc15.86-164.04%
PBYIPuma Biotechnology Inc17.32-169.94%
CPRXCatalyst Pharmaceuticals Inc17.44-170.44%
EXELExelixis Inc17.54-170.84%
TGTXTG Therapeutics Inc18.97-176.60%
MDXGMimedx Group Inc20.55-183.01%
XOMAXOMA Royalty Corp22.87-192.39%
ARGXArgen X SE24.30-198.14%
CTMXCytomX Therapeutics Inc24.82-200.25%
XOMAOXOMA Royalty Corp25.34-202.37%
HALOHalozyme Therapeutics Inc25.62-203.50%
XOMAPXOMA Royalty Corp25.67-203.68%
VRTXVertex Pharmaceuticals Inc27.99-213.07%
RPRXRoyalty Pharma plc - Class A28.69-215.87%
SLNOSoleno Therapeutics Inc29.02-217.19%
ASNDAscendis Pharma A/S30.09-221.52%
LGNDLigand Pharmaceuticals Inc - Class B37.91-253.13%
APLSApellis Pharmaceuticals Inc39.02-257.61%
BMRNBiomarin Pharmaceutical Inc42.21-270.50%
KRYSKrystal Biotech Inc45.34-283.14%
ONCBeiGene Ltd69.54-380.88%
PHARPharming Group N.V.75.03-403.03%
TECHBio-Techne Corp101.96-511.82%
VCELVericel Corp109.92-543.98%
ALNYAlnylam Pharmaceuticals Inc117.96-576.47%
GMABGenmab140.29-666.64%
TLXTelix Pharmaceuticals Ltd162.15-754.94%
CORTCorcept Therapeutics Inc212.86-959.74%